The United States Securities and Exchange Commission (SEC) has declared that NexImmune, Inc.'s submission has become effective as of August 28, 2024. The submission, identified by accession number 0001193125-24-207752, was a post-effective amendment (POS AM) to a previously filed registration statement. This notice of effectiveness indicates that the SEC has reviewed and accepted the company's submission, allowing NexImmune to proceed with the actions outlined in the amendment.

The United States Securities and Exchange Commission (SEC) has declared that NexImmune, Inc.'s submission has become effective as of August 28, 2024. The submission, identified by accession number 0001193125-24-207752, was a post-effective amendment (POS AM) to a previously filed registration statement. This notice of effectiveness indicates that the SEC has reviewed and accepted the company's submission, allowing NexImmune to proceed with the actions outlined in the amendment.